DEMKIP Science og IT ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  20.6% 18.7% 16.5% 17.4% 19.3%  
Credit score (0-100)  6 7 10 8 6  
Credit rating  B B BB B B  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10

Net sales  0 0 0 0 0  
Gross profit  -22.5 -22.1 31.5 21.6 -9.9  
EBITDA  -22.5 -22.1 31.5 21.6 -9.9  
EBIT  -22.5 -22.1 31.5 21.6 -9.9  
Pre-tax profit (PTP)  -22.5 -28.0 -127.5 10.7 -20.7  
Net earnings  -22.5 -28.0 -127.5 10.7 -20.7  
Pre-tax profit without non-rec. items  -22.5 -28.0 -128 10.7 -20.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -98.2 -126 -239 -228 -249  
Interest-bearing liabilities  219 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  167 131 32.0 2.1 0.7  

Net Debt  120 -62.2 -32.0 -2.1 -0.7  
 
See the entire balance sheet

Volume 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -22.5 -22.1 31.5 21.6 -9.9  
Gross profit growth  0.0% 1.6% 0.0% -31.6% 0.0%  
Employees  1 0 0 0 0  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  167 131 32 2 1  
Balance sheet change%  289.7% -21.8% -75.5% -93.5% -65.0%  
Added value  -22.5 -22.1 31.5 21.6 -9.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 2.0 -1.0  

Profitability 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -11.7% -8.5% 7.4% 8.6% -4.1%  
ROI %  -15.2% -20.2% 0.0% 0.0% 0.0%  
ROE %  -21.4% -18.8% -156.9% 63.1% -1,483.8%  

Solidity 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10
Equity ratio %  -37.0% -49.2% -88.2% -99.1% -99.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -535.2% 281.2% -101.5% -9.6% 7.3%  
Gearing %  -222.8% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 5.4% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10
Quick Ratio  0.6 0.5 0.1 0.0 0.0  
Current Ratio  0.6 0.5 0.1 0.0 0.0  
Cash and cash equivalent  98.5 62.2 32.0 2.1 0.7  

Capital use efficiency 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -110.2 -138.2 -238.7 -228.0 -248.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/10
2020
2020/10
2021
2021/10
2022
2022/10
2023
2023/10
Net sales / employee  0 0 0 0 0  
Added value / employee  -22 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -22 0 0 0 0  
EBIT / employee  -22 0 0 0 0  
Net earnings / employee  -22 0 0 0 0